Ascendis Pharma A (ASND) Cash & Current Investments (2012 - 2026)
Ascendis Pharma A (ASND) reported Cash & Current Investments of $944.14 million for the quarter ended Jun 30, 2026, down 24.2% from $1.25 billion a year earlier but up 40.8% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Cash & Current Investments (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, Ascendis Pharma A posted Cash & Current Investments of $696.01 million, down 50.0% from the prior year.
- Cash & Current Investments has a five-year compound annual growth rate of -3.6% (years ended Dec 2020 to Dec 2025).
- By year, Cash & Current Investments came in at $1.39 billion in the year ended Dec 31, 2024 (+228.4%), $424.21 million in the year ended Dec 31, 2023 (-12.8%), $486.64 million in the year ended Dec 31, 2022 (-23.2%) and $633.56 million in the year ended Dec 31, 2021 (-24.1%).
- Five-year quarterly Cash & Current Investments spans a low of $278.59 million in the quarter ended Jun 30, 2024 and a high of $1.42 billion in the quarter ended Sep 30, 2025.
- Year over year, Cash & Current Investments has now declined in each of the last three quarters, with growth averaging 105.3% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was the quarter ended Jun 30, 2025 (growth of 347.1%); the low point was the quarter ended Dec 31, 2025 (a decline of 47.9%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $670.63 million (quarter ended Mar 31, 2026), $717.1 million (quarter ended Dec 31, 2025) and $1.42 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Ascendis Pharma A | 14.12 Bn | 10.37 Bn | 362.22 Mn | 944.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 944.14 Mn |
| Mar 31, 2026 | 670.63 Mn |
| Dec 31, 2025 | 717.10 Mn |
| Sep 30, 2025 | 1.42 Bn |
| Jun 30, 2025 | 1.25 Bn |
| Mar 31, 2025 | 1.16 Bn |
| Dec 31, 2024 | 1.38 Bn |
| Sep 30, 2024 | 686.95 Mn |
| Jun 30, 2024 | 278.59 Mn |
| Mar 31, 2024 | 347.90 Mn |
| Dec 31, 2023 | 421.94 Mn |
| Sep 30, 2023 | 480.36 Mn |
| Jun 30, 2023 | 429.28 Mn |
| Mar 31, 2023 | 538.05 Mn |
| Dec 31, 2022 | 471.07 Mn |
| Sep 30, 2022 | 628.83 Mn |
| Jun 30, 2022 | 759.86 Mn |
| Mar 31, 2022 | 945.15 Mn |
| Dec 31, 2021 | 515.70 Mn |
| Sep 30, 2021 | 901.63 Mn |
API Access
Ascendis Pharma A Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();